Appeal announcement: Pemetrexed disodium for the treatment of malignant pleural mesothelioma

The Institute has received two appeals from Eli Lilly and Company and Royal College of Nursing against the Final Appraisal Determination and Guidance on this technology.

As set out in the Guidance for Appellants members of the public, including consultees and commentators for this appraisal, and the press, may request to attend the hearing. The number of observers admitted to the hearing will be limited to a number appropriate for the venue, and priority will be given to members of the public who are not employed by the appellant(s).

A hearing will be held at NICE offices on 27 October 2006 starting at 10.00am

Members of the public will be able to register to attend the appeal hearing from 11 September 2006. The Institute will not accept early requests to attend.

The name(s) of the appellant(s) will be published on this page on the day of the appeal. The Institute will not comment on speculation as to the identity of appellants prior to publication of this information on the Institute's website.

This page was last updated: 30 March 2010